首页> 外文期刊>Bone marrow transplantation >Deconditioning, fatigue and impaired quality of life in long-term survivors after allogeneic hematopoietic stem cell transplantation
【24h】

Deconditioning, fatigue and impaired quality of life in long-term survivors after allogeneic hematopoietic stem cell transplantation

机译:同种异体造血干细胞移植后长期幸存者的脱墨性,疲劳和寿命受损

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Long-term survivors after allogeneic hematopoietic stem cell transplantation (allo-HSCT) are at high risk for treatment-related adverse events, that may worsen physical capacity and may induce fatigue and disability. The aims of this prospective study were to evaluate exercise capacity in allotransplant survivors and its relationship with fatigue and disability. Patient-reported outcomes and exercise capacity were evaluated in 71 non-relapse patients 1 year after allo-HSCT, using validated questionnaires, cardiopulmonary exercise testing (CPET) with measure of peak oxygen uptake (peakVO(2)) and deconditioning, pulmonary function testing, echocardiography and 6-min walk test. A high proportion (75.4%) of allo-HSCT survivors showed abnormal cardiopulmonary exercise testing parameters as compared to predicted normal values, including 49.3% patients who exhibited moderate to severe impairment in exercise capacity and 37.7% patients with physical deconditioning. PeakVO(2) values were not accurately predicted by 6-min walk distances (r=0.53). Disability and fatigue were strongly associated with decreased peakVO(2) values (p=0.002 and p=0.008, respectively). Exercise capacity was reduced in most allo-HSCT long-term survivors. Because reduced exercise capacity was associated with fatigue, disability and a decrease in quality of life, cardiopulmonary exercise testing should be performed in every patient who reports fatigue and disability.
机译:同种异体造血干细胞移植(Allo-HSCT)的长期幸存者处于高风险的治疗相关的不良事件,这可能会恶化的身体容量,并且可能导致疲劳和残疾。该前瞻性研究的目的是评估同种异体植物幸存者的运动能力及其与疲劳和残疾的关系。在Allo-HSCT后1年内评估患者报告的结果和运动能力,使用验证的调查问卷,心肺锻炼测试(CPET),具有峰值氧吸收(Peakvo(2))和肺功能测试的肺功能测试,超声心动图和6分钟的步行测试。与预期的正常值相比,高比例(75.4%)的Allo-HSCT幸存者显示出异常的心肺运动测试参数,包括49.3%的患者,在运动能力和37.7%的身体遮挡患者中表现出中度至严重损伤。 PapVo(2)峰值(2)值不准确地预测6分钟步行距离(r = 0.53)。残疾和疲劳与降低的峰值(2)值强烈有关(P = 0.002和P = 0.008)。在大多数Allo-HSCT长期幸存者中,运动能力降低。由于减少的运动能力与疲劳,残疾和生活质量下降有关,因此应在报告疲劳和残疾的每位患者中进行心肺运动测试。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号